Form 8-K - Current report:
SEC Accession No. 0000950170-25-001330
Filing Date
2025-01-03
Accepted
2025-01-03 17:00:08
Documents
12
Period of Report
2024-12-27
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hura-20241227.htm   iXBRL 8-K 53826
2 EX-16.1 hura-ex16_1.htm EX-16.1 4223
  Complete submission text file 0000950170-25-001330.txt   182317

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hura-20241227.xsd EX-101.SCH 30874
15 EXTRACTED XBRL INSTANCE DOCUMENT hura-20241227_htm.xml XML 4718
Mailing Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612
Business Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612 813-875-6600
TuHURA Biosciences, Inc./NV (Filer) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 25507478
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)